Press "Enter" to skip to content

New patent expiration for Osi Pharms drug TARCEVA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Osi Pharms drug TARCEVA

Annual Drug Patent Expirations for TARCEVA
Annual Drug Patent Expirations for TARCEVA

Tarceva is a drug marketed by Osi Pharms and is included in one NDA. It is available from one supplier. There are four patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for TARCEVA.

The generic ingredient in TARCEVA is erlotinib hydrochloride. One supplier is listed for this compound. Additional details are available on the erlotinib hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Osi Pharms drug TARCEVA
    Do NOT follow this link or you will be banned from the site!